Vestmark Advisory Solutions »

Biosante Pharmaceuticals shares owned by Vestmark Advisory Solutions

Quarter-by-quarter ownership of Biosante Pharmaceuticals (ANIP) shares owned by Vestmark Advisory Solutions from 13F filings

Historical chart of Vestmark Advisory Solutions investment in Biosante Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Biosante Pharmaceuticals held by Vestmark Advisory Solutions consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biosante Pharmaceuticals by Vestmark Advisory Solutions

Quarter filed Position value Share count Share price at filing
2025-12-31 $899k 11k 78.94

More positions owned by Vestmark Advisory Solutions

Vanguard Index Fds Total Stk Mkt (VTI)
J P Morgan Exchange Traded F Betabuildrs Us (BBUS)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Dimensional Etf Trust Us Core Equity 2 (DFAC)
Vanguard Star Fds Vg Tl Intl Stk F (VXUS)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Microsoft Corporation (MSFT)
Apple (AAPL)
NVIDIA Corporation (NVDA)
J P Morgan Exchange Traded F Core Plus Bd Etf (JCPB)
J P Morgan Exchange Traded F Intrnl Res Eqt (JIRE)
Dimensional Etf Trust Global Cr Etf (DGCB)
Spdr Gold Tr Gold Shs (GLD)
Amazon (AMZN)
J P Morgan Exchange Traded F Active Bond Etf (JBND)

View all positions for Vestmark Advisory Solutions

Top funds holding Biosante Pharmaceuticals

BlackRock
Vanguard Group
State Street Corporation
Citadel Advisors
Global Alpha Capital Management
Dimensional Fund Advisors
Soleus Capital Management
Tang Capital Management
Deep Track Capital
Geode Capital Management
Arrowstreet Capital, Limited Partnership
Goldman Sachs Group
Deutsche Bank Aktiengesellschaft
Nuveen
Ranger Investment Management

View all funds holding Biosante Pharmaceuticals